
With over 30 years of expertise in oncology, Prof. Dr. Ke Liqun has transformed the landscape of cancer treatment, diagnosing and treating thousands of patients with precision and care. His deep empathy for cancer patients drives him to merge Western medicine with traditional Chinese therapies, crafting an outstanding approach that addresses both symptoms and root causes. As the mastermind behind the "Four Combinations" principle, he integrates targeted therapies, immune activation, and tumor microenvironment regulation to offer effective, low-toxicity treatments that minimize relapse risks.
His journey of excellence began at Anhui Medical University, followed by advanced studies in minimally invasive cancer therapies in China and Japan. Over the years, he has held prestigious roles, including oncology director and hospital president at outstanding medical institutions. Since 2015, he has been a leading international oncology expert at Modern Cancer Hospital Guangzhou, sharing his groundbreaking techniques worldwide, from Thailand and Indonesia to Saudi Arabia and Vietnam.
Price upon request

Since 1993, Professor Peng has been at the forefront of cancer treatment, dedicating his life to improving patient outcomes. Born into a family of medical experts, he chose oncology as his calling, witnessing the struggles of countless patients. His passion for research led him to attend top oncology conferences, collaborate with global cancer specialists, and publish over 20 academic papers. Constantly updating his knowledge through literature and discussions, he has developed innovative cancer treatment approaches. Professor Peng’s relentless pursuit of excellence continues to bring new hope to cancer patients worldwide. His expertise in advanced cancer therapies has made him a trusted name in oncology. Through continuous research and clinical practice, he strives to enhance treatment effectiveness and patient care. Professor Peng remains committed to pushing the boundaries of cancer treatment innovation.
Price upon request

Dr. Niu Lizhi is a globally recognized thoracic and cardiac surgeon with over 25 years of experience in advanced cancer treatment. He is currently the Chief Specialist at the Minimally Invasive Cryosurgery Centre, where he has performed nearly 10,000 successful cryosurgery procedures for various cancers. Dr. Niu also serves as the Vice President of the International Society of Cryosurgery and is a supervisor for master’s degree courses at Jinan University, reflecting his leadership and expertise in the field.
Dr. Niu began his journey at the Fourth Military Medical University, where he earned his doctoral degree in Thoracic and Cardiac Surgery. He later dedicated his career to developing and refining minimally invasive cryosurgery techniques, achieving global recognition for his work in treating complex cancers. His innovative methods have helped thousands of patients worldwide, from children as young as four to seniors aged 94, including high-profile individuals such as ministers and celebrities.
Key Specializations
Price upon request

Dr. Xu Kecheng is a renowned oncologist and a pioneer in advanced cancer treatments at Fuda Cancer Hospital. With decades of experience, he specializes in complex cancer surgeries, earning global recognition for his expertise. As the President and Executive Member of the Standing Committee of the International Society of Cryosurgery (ISC), he plays a key role in shaping the future of cryosurgery and minimally invasive cancer treatments.
Beyond his clinical achievements, Dr. Xu is actively engaged in medical research and education. He serves as the Vice Director of the Gastroenterology Society under the Chinese Association of Integrative Traditional Chinese and Western Medicine, bridging innovative treatment approaches. His past contributions include leadership roles in the Pancreatic Disease Group and HP Group of the Digestive Disease Society under the Chinese Medical Association.
His influence extends to Guangdong and Shenzhen, where he previously held the positions of Vice-Chairman of the Digestive Disease Committee in the Guangdong Medical Association and Chairman of the Endoscopy-Digestive Disease Committee in the Shenzhen Medical Association. His dedication to research is further highlighted as the Chairman of the National Clinical Research of Breath Test Association and an esteemed researcher in the International Hepatic Disease Association.
Price upon request

When it comes to head and neck tumor treatment, few specialists are as renowned as Prof. Zeng Zongyuan, a Chief Physician, Doctoral Supervisor, and Chief Expert at Fuda Cancer Hospital. With over 40 years of experience, he has dedicated his career to pioneering advancements in laryngeal cancer treatment and oral cancer treatment, offering patients innovative and life-changing solutions. A graduate of the Medical Department of Sun Yat-sen University, Prof. Zeng has held esteemed positions, including Vice President of the Tumor Hospital affiliated with Sun Yat-sen University and Deputy Director of Sun Yat-sen University Cancer Center. He is widely recognized as a “Zero Bleeding” expert, having developed groundbreaking surgical techniques such as Intermittent Blocked Ligation Therapy and Cross-stitched Chained Mattress Suture, which significantly reduce bleeding during surgery, improving recovery and patient outcomes. His expertise extends to treating thyroid cancer, parotid tumors, and facial and cervical hemangiomas, offering minimally invasive cancer treatments for patients who may not be suitable for traditional surgery. As the head of the Head & Neck Cancer Center, he specializes in cutting-edge treatments such as Nanoknife Therapy (Irreversible Electroporation), Cryosurgical Ablation, Microvascular Interventional Therapy, Photodynamic Therapy, and Brachytherapy, ensuring better survival rates and fewer complications. His commitment to innovation and patient-centered care makes him a trusted name in advanced cancer treatment. If you or a loved one is seeking expert head and neck cancer treatment, Prof. Zeng Zongyuan at Fuda Cancer Hospital offers hope, expertise, and the latest medical advancements. Book a consultation today and explore world-class care from a leader in the field.
Price upon request
China has become a significant center for bone marrow transplantation because major hospitals offer high case volumes, rigorous specialist training, and structured patient safety systems. Many centers work with international standards for infection control and transplant monitoring. Typical costs for a bone marrow transplant in China range from USD 60000 to USD 120000, depending on factors such as treatment complexity, donor source, and the experience level of the medical team. Most patients follow a day based recovery pattern, with light activity often possible within 5 to 7 days after initial stabilization, although full recovery is a longer process that varies by condition.
Patients also benefit from detailed evaluation and surgical planning, which helps doctors tailor each transplant protocol. This is important because suitability for a transplant depends on overall health, donor match, and specific blood disease characteristics. A short safety note is essential: this information is for educational purposes and does not replace an in person consultation with a qualified specialist.
Suitability for this procedure depends on individual health status, so each patient needs a personalized evaluation by a qualified doctor.
China is known for transplant programs that combine specialized hematology training with extensive clinical experience in autologous and allogeneic transplants. Many doctors work in accredited hospitals that maintain high infection control standards and advanced transplant units. International patients often ask whether communication is smooth, and many major centers provide multilingual support teams to help guide each step.
Several subspecialty physicians in China bring advanced training and careful clinical planning to every case. Their experience helps patients understand expected milestones, such as when blood counts typically begin to recover or how follow up care is structured over the first year. These doctors also emphasize recovery guidance and follow up care, which is essential for monitoring graft success and minimizing complications.
In Beijing, Professor Xiaojun Huang at Peking University People's Hospital is widely regarded for his leadership in hematopoietic stem cell transplantation. His work on the Beijing Protocol has expanded access to haploidentical transplants when fully matched donors are not available. His approach includes staged evaluations and careful post transplant monitoring.
In Beijing as well, Guo Mei at the 307th Hospital of the Chinese People's Liberation Army is recognized for her work with micro transplantation methods for leukemia and aplastic anemia. She draws on a large body of research experience, integrates modern diagnostic tools, and provides structured follow up pathways to help track early recovery patterns.
In Shanghai, Hu Jiong at Ruijin Hospital and Jiahui International Cancer Center leads a high level transplant program with expertise in both autologous and allogeneic procedures. His team uses modern transplant protocols and imaging tools to support clear communication about risks, limitations, and realistic outcomes.
Best Clinic Abroad supports patients who want safe access to experienced bone marrow transplant doctors in China. The team helps organize consultations, clarify treatment options, and coordinate logistics around each medical stay.
➤ Virtual consultation support - Arrange remote assessments and medical report reviews before travel.
➤ Transparent cost guidance - Provide indicative price ranges and explain what factors can influence final expenses.
Patients who are considering a bone marrow transplant in China can share their medical reports with Best Clinic Abroad to receive coordinated support and a clear starting point for their treatment planning.